ImmunityBio, Inc.
NASDAQ:IBRX
2.9 (USD) • At close March 13, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -413.645 | -583.196 | -417.32 | -349.848 | -224.187 | -160.158 | -96.226 | -96.423 | -120.809 | -236.876 | -6.213 | -2.047 |
| Afschrijvingen & Amortisatie
| 22.587 | 18.512 | 18.26 | 14.238 | 12.739 | 14.042 | 9.555 | 5.566 | 3.607 | 1.472 | 0.128 | 0.004 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | -0.004 | -0.008 | -2.938 | -0.008 | -0.498 | -0.497 | -0.575 | -0.302 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 34.432 | 49.163 | 40.179 | 57.181 | 2.187 | 3.421 | 2.043 | 36.997 | 73.852 | 211.221 | 0 | 0 |
| Verandering in Werkkapitaal
| 0 | 3.977 | -8.001 | -19.112 | 16.36 | -15.636 | -0.554 | 3.228 | 3.842 | 0.282 | 60.988 | 0.856 |
| Vorderingen
| -2.36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.458 | 0.075 | 0.095 | -0.173 |
| Voorraden
| -8.272 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -3.167 | -6.476 | 8 | -3.717 | 2.57 | 1.188 | -1.1 | 0.15 | 0.888 | 0.627 | -0.347 | 0.7 |
| Overig Werkkapitaal
| 0 | 10.453 | -16.001 | -15.395 | 13.79 | -16.824 | 0.546 | 3.078 | 2.954 | -0.42 | 61.24 | 0.329 |
| Overige Niet-Contante Posten
| -34.61 | 144.787 | 29.377 | 23.13 | 24.115 | 6.23 | 44.552 | 50.328 | 81.668 | 212.361 | -61.046 | -0.365 |
| Kasstroom uit Operationele Activiteiten
| -391.236 | -366.757 | -337.509 | -274.419 | -171.724 | -152.109 | -63.381 | -48.78 | -38.593 | -25.305 | -5.354 | -0.668 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -6.888 | -30.584 | -99.391 | -33.563 | -1.669 | -4.287 | -13.102 | -34.815 | -6.56 | -2.241 | -0.299 | -0.003 |
| Netto Overnames
| -1 | 0 | -1 | 20.498 | 0.008 | 0.2 | 0.412 | -0.032 | -0.137 | -1.818 | 0 | 0 |
| Aankoop van Beleggingen
| -140.218 | -10.358 | -34.312 | -141.75 | -91.765 | -87.192 | -95.493 | -119.855 | -272.999 | -198.068 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 136.607 | 10.472 | 162 | 69.929 | 73.622 | 112.331 | 165.284 | 254.222 | 165.887 | 26.903 | 0 | 0 |
| Overige Investeringsactiviteiten
| -0.747 | 0 | 105.459 | -51.323 | -0.008 | -2.5 | 35.026 | 0.032 | 0.137 | -1.818 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -12.246 | -30.47 | 27.297 | -84.886 | -19.812 | 18.552 | 57.101 | 99.552 | -113.672 | -175.224 | -0.299 | -0.003 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -0.064 | 258.623 | 174.067 | 338.5 | 63.7 | 47.67 | -0.477 | -19.932 | -0.032 | -0.132 | -0.053 | -0.001 |
| Uitgifte van Gewone Aandelen
| 111.357 | 110.397 | 60.427 | 164.53 | 86.302 | 30 | 0.057 | 1.215 | 1.425 | 324.678 | 0 | 0.676 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | -2.501 | -0.228 | -15.227 | -15.847 | -4.798 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 170.337 | 189.615 | -0.881 | 2.413 | 0.673 | 39.11 | -0.123 | -1.039 | -1.106 | -2.415 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 281.63 | 558.341 | 233.613 | 505.443 | 150.675 | 114.279 | -0.771 | -34.983 | -15.56 | 317.333 | 64.407 | 0.905 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | -0.292 | 0.284 | 0.048 | -0.025 | -0.021 | -0.03 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -121.875 | 160.822 | -76.315 | 146.186 | -40.886 | -19.299 | -7.051 | 15.789 | -167.825 | 116.804 | 58.754 | 0.234 |
| Kaspositie aan het Einde van de Periode
| 143.912 | 265.787 | 104.965 | 181.28 | 35.094 | 75.98 | 16.821 | 23.872 | 8.083 | 175.908 | 59.104 | 0.35 |